Pfreundschuh, M., & Witzens-Harig, M. (2014). Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II): Extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group. Journal of clinical oncology, 32(36), . https://doi.org/10.1200/JCO.2013.54.6861
Chicago-Zitierstil (17. Ausg.)Pfreundschuh, Michael, und Mathias Witzens-Harig. "Optimization of Rituximab for the Treatment of Diffuse Large B-Cell Lymphoma (II): Extended Rituximab Exposure Time in the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group." Journal of Clinical Oncology 32, no. 36 (2014). https://doi.org/10.1200/JCO.2013.54.6861.
MLA-Zitierstil (9. Ausg.)Pfreundschuh, Michael, und Mathias Witzens-Harig. "Optimization of Rituximab for the Treatment of Diffuse Large B-Cell Lymphoma (II): Extended Rituximab Exposure Time in the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group." Journal of Clinical Oncology, vol. 32, no. 36, 2014, https://doi.org/10.1200/JCO.2013.54.6861.